Previous close | 328.74 |
Open | 331.02 |
Bid | 133.11 x 1000 |
Ask | 532.43 x 1000 |
Day's range | 328.54 - 334.18 |
52-week range | 284.01 - 463.59 |
Volume | |
Avg. volume | 331,608 |
Market cap | 16.482B |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | 17.62 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.06 (0.02%) |
Ex-dividend date | 26 Jul 2022 |
1y target est | N/A |
SAN RAMON, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that Nicholas Khadder has been appointed as its general counsel and corporate secretary. Khadder joins Cooper having previously served as general counsel of Standard BioTools Inc. (formerly Fluidigm Corporation) from June 2016 to July 2022. Prior to joining Fluidigm, from 2010 to June 2016, Khadder held various positions at Amyris, Inc., including general counsel and corporate secretary from 2013 to
SAN RAMON, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release third quarter 2022 financial results on Wednesday, August 31, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. To participate in the call please follow this link to register and receive the dial-in information. A simultaneous webcast of the call will be available through the “In
SAN RAMON, Calif., July 13, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on August 11, 2022, to stockholders of record on July 27, 2022. About CooperCompaniesCooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperV